SPARC Inhibits LPA-Mediated Mesothelial—Ovarian Cancer Cell Crosstalk
The interplay between peritoneal mesothelial cells and ovarian cancer cells is critical for the initiation and peritoneal dissemination of, and ascites formation in, ovarian cancer. The production of lysophosphatidic acid (LPA) by both peritoneal mesothelial cells and ovarian cancer cells has been...
Main Authors: | Neveen A. Said, Ida Najwer, Matthew J. Socha, David J. Fulton, Samuel C. Mok, Kouros Motamed |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2007-01-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558607800133 |
Similar Items
-
Fibrosis of mesothelial cell-induced peritoneal implantation of ovarian cancer cells
by: Wang J, et al.
Published: (2018-12-01) -
SPARC Inhibits Metabolic Plasticity in Ovarian Cancer
by: Christine Naczki, et al.
Published: (2018-10-01) -
A Unique Pattern of Mesothelial-Mesenchymal Transition Induced in the Normal Peritoneal Mesothelium by High-Grade Serous Ovarian Cancer
by: Martyna Pakuła, et al.
Published: (2019-05-01) -
Production of IL1-beta by ovarian cancer cells induces mesothelial cell beta1-integrin expression facilitating peritoneal dissemination
by: Watanabe Takafumi, et al.
Published: (2012-02-01) -
Ascites from ovarian cancer patients stimulates MUC16 mucin expression and secretion in human peritoneal mesothelial cells through an Akt-dependent pathway
by: Isabelle Matte, et al.
Published: (2019-04-01)